The NIH announced that it is launching a phase 2 human challenge trial of AV-1, an investigational monoclonal antibody to ...
Re: “ Judge temporarily blocks Trump move to cut NIH funding ” (Page A1, Feb. 11).
The HEARTS Act directs the NIH to provide incentives to researchers to use non-animal methods whenever feasible and applicable, and establishes a dedicated center within the NIH devoted to advancing ...
The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.
If AV-1 shows promising results in this clinical trial, researchers may pursue further clinical evaluations of its safety and ...
Fraud, Arrogance, and Tragedy in the Quest to Cure Alzheimer’s,” Charles Piller looks how the amyloid hypothesis took over ...
The significant Wall Street Journal has already ended up speculating that amongst which US President Donald Trump cabinet pick will be the very first to leave the position and the speculations are ...
Emory’s study comes as Georgia cities grapple with PFAS in their drinking water, along with new federal regulations that will soon require them to remove nearly all of them.
After weeks of disruption to scientific federal grants, the National Institutes of Health has fallen behind in funding ...
Changes to a key funding formula will reduce research grants at hospitals and universities by billions — and may discourage ...
The University of New Mexico said Tuesday it is not stopping its research after a federal judge's ruling on Monday to halt the Trump administration's plan to limit funding for overhead costs ...
There exists no ‘amyloid cabal’” in Alzheimer’s research, neurologist Dennis Selkoe writes in response to Charles Piller’s “Doctored.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results